NCT00538603View on ClinicalTrials.gov

Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Epithelial Ovarian Cancer
Interventions
DRUG

pegylated liposomal Doxorubicin (CAELYX) & Carboplatin

Chemotherapy

DRUG

Paclitaxel & Carboplatin

Chemotherapy

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT00538603 - Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) | Biotech Hunter | Biotech Hunter